SNORD116 and Prader-Willi syndrome: Recent studies have shown that histone methyltransferase inhibitors are capable of reactivating the expression of paternally expressed SNRPN and SNORD116 from the maternal chromosome, both in PWS mouse models and in cultured PWS patient-derived fibroblasts (149, 150).